CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerhan, J. R.
Right arrow Articles by Folsom, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerhan, J. R.
Right arrow Articles by Folsom, A. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 1114-1120, July 2004
© 2004 American Association for Cancer Research

Adherence to the AICR Cancer Prevention Recommendations and Subsequent Morbidity and Mortality in the Iowa Women's Health Study Cohort

James R. Cerhan1, John D. Potter2, Julie M.E. Gilmore3, Carol A. Janney1, Larry H. Kushi4, DeAnn Lazovich5, Kristin E. Anderson5, Thomas A. Sellers1 and Aaron R. Folsom5

1 Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota; 2 Division of Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3 Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa; 4 Department of Research, Kaiser Permanente, Oakland, California; and 5 Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis, Minnesota

Requests for reprints: James R. Cerhan, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905. Phone: 507-538-0499; Fax: 507-266-2478. E-mail: cerhan.james{at}mayo.edu

In 1997, the American Institute for Cancer Research (AICR) published 14 recommendations related to diet for individuals to reduce cancer incidence on a global basis; smoking was also discouraged. We operationalized these into nine recommendations that are particularly relevant to western populations in a cohort of 29,564 women ages 55 to 69 years at baseline in 1986 who had no history of cancer or heart disease. The cohort was followed through 1998 for cancer incidence (n = 4,379), cancer mortality (n = 1,434), cardiovascular disease (CVD) mortality (n = 1,124), and total mortality (n = 3,398). The median number (range) of recommendations followed was 4 (0-8), and 33% of the cohort had ever smoked. Women who followed no or one recommendation compared with six to nine recommendations were at an increased risk of cancer incidence [relative risk (RR) 1.35, 95% confidence interval (CI) 1.15-1.58] and cancer mortality (RR 1.43, 95% CI 1.11-1.85), but there was no association with CVD mortality (RR 1.06, 95% CI 0.78-1.43). We calculated the population attributable risk (PAR) to estimate the proportion of cancer incidence, cancer mortality, and CVD mortality that theoretically would have been avoidable if the entire cohort had never smoked, had followed six to nine recommendations, or had done both. The PARs for smoking were 11% (95% CI 10-13) for cancer incidence, 21% (95% CI 17-24) for cancer mortality, and 20% (95% CI 16-23) for CVD mortality. The PARs for not following six to nine recommendations were 22% (95% CI 12-30) for cancer incidence, 11% (95% CI –5 to 24) for cancer mortality, and 4% (95% CI –20 to 19) for CVD mortality. When smoking and the operationalized AICR recommendations were combined together, the PARs were 31% (95% CI 19-37) for cancer incidence, 30% (95% CI 15-40) for cancer mortality, and 22% (95% CI 4-36) for CVD mortality. These data suggest that the adherence to the AICR recommendations, independently and in conjunction with not smoking, is likely to have a substantial public health impact on reducing cancer incidence and, to a lesser degree, cancer mortality at the population level.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
R. S Rivlin
Keeping the young-elderly healthy: is it too late to improve our health through nutrition?
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1572S - 1576S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Canene-Adams, B. L. Lindshield, S. Wang, E. H. Jeffery, S. K. Clinton, and J. W. Erdman Jr.
Combinations of Tomato and Broccoli Enhance Antitumor Activity in Dunning R3327-H Prostate Adenocarcinomas
Cancer Res., January 15, 2007; 67(2): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. J. Gillies and E. S. Krul
Using Genetic Variation to Optimize Nutritional Preemption
J. Nutr., January 1, 2007; 137(1): 270S - 274S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. L. W. Go, D. A. Wong, Y. Wang, R. R. Butrum, H. A. Norman, and L. Wilkerson
Diet and Cancer Prevention: Evidence-based Medicine to Genomic Medicine
J. Nutr., December 1, 2004; 134(12): 3513S - 3516S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.